Alisha kapoor

Hey there, I’m Alisha. I’m a teacher living in India. I am a fan of animals, martial arts, and basketball. I’m also interested in rugby and homesteading. and I want to share one thing one of my friends is suffering from T-cell acute lymphoblastic leukemia and she wants treatment but she is not able to find Atrience medicine. so I am going to tell you about Atrience

Atriance injection also called nelarabine is a chemotherapy drug used in the treatment of t-cell acute lymphoblastic leukemia or t-cell acute lymphoblastic lymphoma.
Both types of cancer result in the rapid multiplication of T-lymphoblast. In leukemia, the abnormal cells are accumulated in the bone marrow and blood however in lymphoma these are accumulated in the lymphatic system.

Nelarabine is generally used in a patient who has failed the response of at least two types of chemotherapy.
This drug is available in injection form that is injected intravenously. The frequency of infusion and dose of the patient depends upon patient age and body surface area. Atriance injection should be stopped if a patient develops any serious side effects of a brain or lymphatic system.

T-cell acute lymphoblastic leukaemia prognosis:T-cell acute lymphoblastic leukaemia is a rare disease in adults when compared to pediatric patients. Although 50% of total patients suffering from leukemia have a survival rate of approximately 5 years adult patients suffering from the relapsed disease have less than 10% of patients with a 5-year survival expectancy.

How Does Nelarabine Work:It is a purine nucleoside analog that causes cytotoxicity and inhibition of DNA synthesis. It is a prodrug of Arabinosylguanine nucleotide triphosphate.
The active substance nelarabine is a cytotoxic element that kills the cell that is dividing. It belongs to a group of anticancer, called antimetabolites. This compound takes the place of guanine and interferes with the activity of the production of new DNA polymerases.

Atriance medical facts:

• It contains an active ingredient nelarabine that is cytotoxic.
  This drug holds approval by the FDA in August 2008.
  This medicine must be stored at room temperature at 25° C (77° F).

Conclusion:This medication is an effective treatment method for t-cell acute lymphoblastic leukemiaand t-cell acute lymphoblastic lymphoma. This injection contains nelarabine which works by inhibiting DNA production and causes an increased rate of cell death.